Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-C chemokine receptor type 9 (CCR9) is a seven-transmembrane G protein-coupled receptor that binds to CCL25/TECK. It regulates migration, maturation, proliferation, and apoptosis of leukocytes, particularly T lymphocytes. CCR9 is highly expressed in the thymus, small intestine, and colon and plays a key role in directing immune cell homing to the small intestine. It is implicated in various inflammation-related diseases and cancer.
Binding of CCL25 (TECK) to CCR9 activates intracellular signaling pathways that increase intracellular calcium levels and promote cell migration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-C Chemokine Receptor Type 9 (CCR9).